[1]
“Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signalling”, Swiss Med Wkly, vol. 144, no. 0304, p. w14043, Jan. 2015, doi: 10.4414/smw.2015.14043.